Loading...
•
Mar 31, 2020
Globus Medical Q1 2020 Earnings Report
Globus Medical's Q1 2020 financial results were announced, revealing a sales increase and resilience amidst the COVID-19 pandemic.
Key Takeaways
Globus Medical reported a 4.2% increase in worldwide sales, reaching $190.6 million in Q1 2020. Despite the COVID-19 pandemic's estimated $20 million negative impact on sales, the company maintained profitability with a net income of $25.9 million and a non-GAAP adjusted EBITDA of 26.5% of sales. The company launched three new spine products during the quarter and ended the quarter with $657 million in cash, cash equivalents and marketable securities.
Worldwide sales increased by 4.2% to $190.6 million.
Net income for the first quarter was $25.9 million.
Diluted EPS was $0.25, and non-GAAP diluted EPS was $0.29.
Non-GAAP adjusted EBITDA was 26.5% of sales.
Globus Medical
Globus Medical
Globus Medical Revenue by Segment
Globus Medical Revenue by Geographic Location
Revenue by Segment
Musculoskeletal Solutions Revenue
CapyFin.comEnabling Technologies Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
Globus Medical withdrew its full year 2020 guidance due to the uncertainties related to the COVID-19 pandemic.
Revenue & Expenses
Visualization of income flow from segment revenue to net income